mometasone furoate (Asmanex, Nasonex)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Inhaled glucocorticoid (Asmanex).

Indications

Contraindications

pregnancy category = c

safety in lactation = ?

Dosage

'Twisthaler' device (dry powder inhaler) contains 30, 60 or 120 inhalations delivers 200 ug of mometasone furoate from the mouthpiece

Nasonex nasal spray 1-2 whiffs QD (generic FDA-approved March 2016)[4]

Pharmacokinetics

  • maximum benefit may take 2 weeks or longer

Adverse effects

Drug interactions

  • no significant drug interactions in clinical trials

Mechanism of action

More general terms

More specific terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996.
  2. Prescriber's Letter 12(9): 2005 Asmanex (Mometasone Furoate Inhalation Powder) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210906&pb=PRL (subscription needed) http://www.prescribersletter.com
  3. Deprecated Reference
  4. 4.0 4.1 Apotex News Release. Mar 22, 2016 Apotex Launches First Generic Version of Merck's Nasonex<TM> http://www.prnewswire.com/news-releases/apotex-launches-first-generic-version-of-mercks-nasonex-573064911.html
  5. Department of Veterans Affairs, VA National Formulary

Database